122 related articles for article (PubMed ID: 6889513)
1. Plasma concentrations of carminomycin and carminomycinol in man, measured by high pressure liquid chromatography.
Lankelma J; Penders PG; McVie JG; Leyva A; Ten Bokkel-Huinink WW; de Planque MM; Pinedo HM
Eur J Cancer Clin Oncol; 1982 Apr; 18(4):363-7. PubMed ID: 6889513
[TBL] [Abstract][Full Text] [Related]
2. Analysis of carminomycin in human serum by fluorometric high-performance liquid chromatography.
Fandrich SE; Pittman KA
J Chromatogr; 1981 Apr; 223(1):155-64. PubMed ID: 7251757
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of carminomycin in dogs and humans. Preliminary report.
Reich SD; Fandrich SE; Finkelstein TT; Schurig JE; Florczyk AP; Comis RL; Crooke ST
Cancer Chemother Pharmacol; 1981; 6(2):189-93. PubMed ID: 7307236
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of carminomycin in man: biweekly schedule vs single dose every three weeks.
Weenen H; Pinedo HM; de Planque MM; Ten Bokkel Huinink WW; McVie JG; Lankelma J
Eur J Cancer Clin Oncol; 1984 Jul; 20(7):915-8. PubMed ID: 6540192
[TBL] [Abstract][Full Text] [Related]
5. Carminomycin vs adriamycin in advanced soft tissue sarcomas: an EORTC randomised phase II study.
Bramwell VH; Mouridsen HT; Mulder JH; Somers R; Van Oosterom AT; Santoro A; Thomas D; Sylvester R; Markham D
Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1097-104. PubMed ID: 6352280
[TBL] [Abstract][Full Text] [Related]
6. [Determination of carminomycin and its basic metabolite 13-dihydrocarminomycin by a highly efficient liquid chromatographic method with a fluorescent detector].
Poteshnykh AV; Shevchenko VE
Antibiotiki; 1982 Nov; 27(11):820-3. PubMed ID: 7181464
[TBL] [Abstract][Full Text] [Related]
7. Carminomycin versus doxorubicin in advanced breast cancer, a randomized phase II study of the E.O.R.T.C. Breast Cancer Cooperative Group.
Van Oosterom AT; Mouridsen HT; Wildiers J; Paridaens R; Cocconi G; Rotmensz N; Sylvester R
Eur J Cancer Clin Oncol; 1986 May; 22(5):601-5. PubMed ID: 3770031
[TBL] [Abstract][Full Text] [Related]
8. A phase I and clinical pharmacology study of intravenously administered carminomycin in cancer patients in the United States.
Comis RL; Issell BF; Pittman K; Ginsberg SJ; Rudolph A; Aust JC; DiFino SM; Tinsley RW; Poiesz BJ; Crooke ST
Cancer Res; 1982 Jul; 42(7):2944-8. PubMed ID: 7083181
[TBL] [Abstract][Full Text] [Related]
9. [Determination of carminomycin in its preparations by high-performance liquid chromatography].
Aleksandrova LG; Rubasheva LM; Zbarskiĭ VB; Brazhnikova MG
Antibiot Khimioter; 1988 Aug; 33(8):574-8. PubMed ID: 3196114
[TBL] [Abstract][Full Text] [Related]
10. [Synthesis and antitumor properties of carminomycin 13-cyclohexylidenhydrazone].
Povarov LS; Bazhanov VS; Averbukh LA; Gol'dberg LE; Tarasova VE
Antibiotiki; 1983 Feb; 28(2):95-9. PubMed ID: 6687665
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis, toxicity and antitumor action of carminomycin azine (carminazine)].
Povarov LS; Gol'dberg LE; Bazhanov VS; Shepelevtseva NG; Vertogradova TP
Antibiotiki; 1981 Aug; 26(8):620-3. PubMed ID: 6895293
[TBL] [Abstract][Full Text] [Related]
12. [Experience with using carminomycin in oncological clinical practice].
Gorbunova VA
Antibiot Khimioter; 1992 Mar; 37(3):35-9. PubMed ID: 1325145
[TBL] [Abstract][Full Text] [Related]
13. [Synthesis and study of the antitumor properties of 13-hydrazone-substituted carminomycin].
Povarov LS; Olsuf'eva EN; Bazhanov VS; Filippos'iants ST; Shepelevtseva NG
Antibiotiki; 1982 Feb; 27(2):137-40. PubMed ID: 6895983
[TBL] [Abstract][Full Text] [Related]
14. Carminomycin. A new anthracycline analog in the treatment of advanced breast cancer.
Aboud A; Yap HY; Esparza L; Blumenschein GR; Hortobagyi G; Issell B; Bodey GP
Cancer; 1984 Jan; 53(1):9-12. PubMed ID: 6546298
[TBL] [Abstract][Full Text] [Related]
15. Phase I clinical study of carminomycin: its activity against soft tissue sarcomas.
Perevodchikova NI; Lichinitser MR; Gorbunova VA
Cancer Treat Rep; 1977 Dec; 61(9):1705-7. PubMed ID: 340034
[No Abstract] [Full Text] [Related]
16. [Carminomycin in drug combination in breast cancer and soft tissue sarcomas].
Lichinitser MR; Assekritova IV; Gorbunova VA
Antibiotiki; 1977 Oct; 22(10):940-3. PubMed ID: 411416
[TBL] [Abstract][Full Text] [Related]
17. [Study of toxicity and antineoplastic activity of 14-substituted derivatives of rubomycin and carminomycin].
Ul'ianova LA; Iudina OI; Tarasova VE; Shepelevtseva NG; Olsuf'eva EN; Povarov LS; Gol'dberg LE
Antibiot Khimioter; 1990 Feb; 35(2):24-6. PubMed ID: 2088341
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic use of carminomycin in soft tissue sarcomas].
Perevodchikova NI; Gorbunova VA; Lichinitser MR; Moroz LV
Antibiotiki; 1976 Jul; 21(7):657-60. PubMed ID: 782353
[TBL] [Abstract][Full Text] [Related]
19. [Comparative evaluation of the results of mono- and polychemotherapy of disseminated forms of breast cancer using the CMFVP program and anthracycline antibiotics (carminomycin and adriamycin)].
Trishkina EA; Gershanovich ML; Pavlov KA; Danova LA; Labkovskiĭ BM
Antibiotiki; 1983 Nov; 28(11):853-8. PubMed ID: 6689116
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancer.
Rozencweig M; ten Bokkel Huinink W; Cavalli F; Bruntsch U; Dombernowsky P; Høst H; Bramwell V; Renard G; Van Glabbeke M; Decoster G
J Clin Oncol; 1984 Apr; 2(4):275-81. PubMed ID: 6584561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
